Patients with obesity and hidradenitis suppurative treated with Wegovy experienced reduced flare-ups and improved quality of ...

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

Novo Nordisk’s CEO Lars Fruergaard Jørgensen faced tough congressional scrutiny over the high prices of its obesity ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...

But what about Ozempic? The explosion of interest in weight-loss medication from brands like Ozempic, Wegovy and Manjaro over the past few years has rocked the medical and pharmaceutical landscape.

The event, reportedly attended by over 10,500 people, highlighted the talents of the musicians while emphasizing the importance of inclusion. Information ...

New York City Mayor Eric Adams has been charged with bribery and illegally soliciting a campaign contribution from a foreign national, according to a federal indictment unsealed on Thursday ...